Photoaffinity analogues of farnesyl pyrophosphate transferable by protein farnesyl transferaseCHEHADE, Kareem A. H; KIEGIEL, Katarzyna; ISAACS, Richard J et al.Journal of the American Chemical Society. 2002, Vol 124, Num 28, pp 8206-8219, issn 0002-7863Article

Farnesyltransferase inhibitorsSEBTI, Said M; ADJEI, Alex A.Seminars in oncology. 2004, Vol 31, Num 1, pp 28-39, issn 0093-7754, 12 p., SUP1Article

Cloning, Solubilization, and Characterization of Squalene Synthase from Thermosynechococcus elongatus BP-1LEE, Sungwon; DALE POULTER, C.Journal of bacteriology. 2008, Vol 190, Num 11, pp 3808-3816, issn 0021-9193, 9 p.Article

Farnesyltransferase inihibitors in hematologic malignanciesHAROUSSEAU, Jean-Luc.Blood reviews. 2007, Vol 21, Num 4, pp 173-182, issn 0268-960X, 10 p.Article

Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitorsJINGXUAN PAN; JIM YEUNG, Sai-Ching.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9109-9112, issn 0008-5472, 4 p.Article

Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor modelsMANNE, Veeraswamy; LEE, Francis Y. F; TAI WAI WONG et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3974-3980, issn 0008-5472, 7 p.Article

Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1DUHADAWAY, James B; WEI DU; DONOVER, Scott et al.Oncogene (Basingstoke). 2003, Vol 22, Num 23, pp 3578-3588, issn 0950-9232, 11 p.Article

Farnesyltransferase inhibitors : a cell signalling approach to the design of efficacious anticancer agentsSEBOLT-LEOPOLD, J. S.Emerging drugs. 1998, Vol 3, pp 271-277, issn 1361-9195Article

Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatinsFULTON, D. C; TAIT, M; THRELFALL, D. R et al.Phytochemistry. 1995, Vol 38, Num 5, pp 1137-1141, issn 0031-9422Article

Mutagenesis and biochemical studies on AuaA confirmed the importance of the two conserved aspartate-rich motifs and suggested difference in the amino acids for substrate binding in membrane-bound prenyltransferasesSTEC, Edyta; LI, Shu-Ming.Archives of microbiology. 2012, Vol 194, Num 7, pp 589-595, issn 0302-8933, 7 p.Article

Protein prenylation, et cetera : Signal transduction in two dimensionsGELB, M. H.Science (Washington, D.C.). 1997, Vol 275, Num 5307, pp 1750-1751, issn 0036-8075Article

Farnesyltransferase inhibitors reverse taxane resistanceMARCUS, Adam I; O'BRATE, Aurora M; BUEY, Ruben M et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8838-8846, issn 0008-5472, 9 p.Article

Measurement of the α-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferasePAIS, June E; BOWERS, Katherine E; FIERKE, Carol A et al.Journal of the American Chemical Society. 2006, Vol 128, Num 47, pp 15086-15087, issn 0002-7863, 2 p.Article

Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibitionGLYNN, Michael W; GLOVER, Thomas W.Human molecular genetics (Print). 2005, Vol 14, Num 20, pp 2959-2969, issn 0964-6906, 11 p.Article

Farnesyl transferase inhibitor resistance probed by target mutagenesisRAZ, Tal; NARDI, Valentina; AZAM, Mohammad et al.Blood. 2007, Vol 110, Num 6, pp 2102-2109, issn 0006-4971, 8 p.Article

1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthaseAMIN, D; CORNELL, S. A; PERRONE, M. H et al.Arzneimittel-Forschung. 1996, Vol 46, Num 8, pp 759-762, issn 0004-4172Article

Characterization of a Squalene Synthase from the Thraustochytrid Microalga Aurantiochytrium sp. KRS101HONG, Won-Kyung; HEO, Sun-Yeon; PARK, Hye-Mi et al.Journal of microbiology and biotechnology. 2013, Vol 23, Num 6, pp 759-765, issn 1017-7825, 7 p.Article

Kinetic characterization of squalene synthase from Trypanosoma cruzi: Selective inhibition by quinuclidine derivativesSEALEY-CARDONA, Marco; CAMMERER, Simon; JONES, Simon et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2123-2129, issn 0066-4804, 7 p.Article

Analysis of squalene synthase expression during the development of Ganoderma lucidumZHAO, M. W; ZHONG, J. Y; LIANG, W. Q et al.Journal of microbiology and biotechnology. 2004, Vol 14, Num 1, pp 116-120, issn 1017-7825, 5 p.Article

Farnesyl transferase inhibitors in myeloid malignanciesLANCET, Jeffrey E; KARP, Judith E.Blood reviews. 2003, Vol 17, Num 3, pp 123-129, issn 0268-960X, 7 p.Article

Les inhibiteurs de la farnésyl-transférase (anti-ras) : une nouvelle classe d'anti-cancéreux = Farnesyl transferase inhibitors (anti-ras).A new class of anticancer drugsLEVY, R.La Presse médicale (1983). 1995, Vol 24, Num 15, pp 725-729, issn 0755-4982Article

Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic functionSIEGEL-LAKHAI, Wandena S; CRUL, Mirjam; DE PORRE, Peter et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4558-4564, issn 0732-183X, 7 p.Article

Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft modelsFERGUSON, Debra; RODRIGUEZ, Luis E; HAIYING ZHANG et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 3045-3054, issn 1078-0432, 10 p.Article

A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumorsMOULDER, Stacy L; MAHANY, John J; SULLIVAN, Daniel M et al.Clinical cancer research. 2004, Vol 10, Num 21, pp 7127-7135, issn 1078-0432, 9 p.Article

Farnesyl protein transferase inhibitors targeting the catalytic zinc for enhanced bindingNJOROGE, F. George; VIBULBHAN, Bancha; PINTO, Patrick et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 23, pp 5877-5880, issn 0960-894X, 4 p.Article